Echo Therapeutics Income Tax

The latest income tax for ECTE is $500K as of September 2016. That compares with $-9.1M in the prior-year period — up 105.5% year over year. Investors often review this figure alongside Echo Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ECTE's income tax moved from $-9.1M to $500K — a 105.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Echo Therapeutics's operating scale or balance-sheet position.

A income tax figure of $500K for ECTE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ECTE's income tax ($500K), review year-over-year change from $-9.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.